BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20817695)

  • 1. Prognostic value of endothelial microparticles in patients with heart failure.
    Nozaki T; Sugiyama S; Sugamura K; Ohba K; Matsuzawa Y; Konishi M; Matsubara J; Akiyama E; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    Eur J Heart Fail; 2010 Nov; 12(11):1223-8. PubMed ID: 20817695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD144(+)EMPs/CD62E(+)EMPs: a couple of new biomarkers to monitor endothelial function in hypertension with hyperlipidemia involved.
    Hu SS; Zhang HG; Zhang QJ; Xiu RJ
    Int J Cardiol; 2014 Jul; 175(1):203. PubMed ID: 24820735
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients.
    Amabile N; Heiss C; Chang V; Angeli FS; Damon L; Rame EJ; McGlothlin D; Grossman W; De Marco T; Yeghiazarians Y
    J Heart Lung Transplant; 2009 Oct; 28(10):1081-6. PubMed ID: 19782291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: a hospital cohort study.
    Pimenta JM; Almeida R; Araújo JP; Azevedo A; Friões F; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    J Card Fail; 2007 May; 13(4):275-80. PubMed ID: 17517347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.
    Koga H; Sugiyama S; Kugiyama K; Watanabe K; Fukushima H; Tanaka T; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2005 May; 45(10):1622-30. PubMed ID: 15893178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure.
    Xue Y; Clopton P; Peacock WF; Maisel AS
    Eur J Heart Fail; 2011 Jan; 13(1):37-42. PubMed ID: 21149316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility.
    Takahashi T; Kobayashi S; Fujino N; Suzuki T; Ota C; He M; Yamada M; Suzuki S; Yanai M; Kurosawa S; Yamaya M; Kubo H
    Thorax; 2012 Dec; 67(12):1067-74. PubMed ID: 22843558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients.
    Pfister R; Diedrichs H; Schiedermair A; Rosenkranz S; Hellmich M; Erdmann E; Schneider CA
    Eur J Heart Fail; 2008 Mar; 10(3):315-20. PubMed ID: 18304872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes.
    Kistorp C; Chong AY; Gustafsson F; Galatius S; Raymond I; Faber J; Lip GY; Hildebrandt P
    Eur J Heart Fail; 2008 Apr; 10(4):380-7. PubMed ID: 18343722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.
    Boldanova T; Noveanu M; Breidthardt T; Potocki M; Reichlin T; Taegtmeyer A; Christ M; Laule K; Stelzig C; Mueller C
    Int J Cardiol; 2010 Jul; 142(3):265-72. PubMed ID: 19185372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure.
    Gardner RS; Chong KS; Morton JJ; McDonagh TA
    Eur J Heart Fail; 2007 Mar; 9(3):266-71. PubMed ID: 17023207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care.
    Alehagen U; Dahlström U; Lindahl TL
    Eur J Heart Fail; 2009 Apr; 11(4):354-60. PubMed ID: 19228797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic threshold levels of NT-proBNP testing in primary care.
    Rosenberg J; Schou M; Gustafsson F; Badskjaer J; Hildebrandt P
    Eur Heart J; 2009 Jan; 30(1):66-73. PubMed ID: 19029123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
    Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
    Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.